Taltz

Taltz (ixekizumab) is a prescription medication used to treat Plaque psoriasis, psoriatic arthritis, ankylosing spondylitis. Taltz is a biologic injection that treats moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis by targeting a protein called IL-17A.

Taltz blocks interleukin-17A (IL-17A), an inflammatory protein that plays a central role in psoriasis and related conditions. Blocking IL-17A helps reduce skin inflammation and joint symptoms.

Commonly reported side effects of Taltz include Injection site reactions, Respiratory infections, Inflammatory bowel disease, Low white blood cell count, and Fungal infections. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Taltz has notable warnings and precautions. Tell your doctor about your medical history and any other medicines or supplements you take before starting Taltz.

The active ingredient in Taltz is ixekizumab, which belongs to a class of medicines known as IL-17A Inhibitor (Biologic).

Taltz is manufactured by Eli Lilly. It was first approved in 2016.

You may be able to lower the cost of Taltz by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.